Population survey of CCR5 Δ32, CCR5 m303, CCR2b 64I, and SDF1 3′A allele frequencies in indigenous Chinese healthy individuals, and in HIV-1-infected and HIV-1-uninfected individuals in HIV-1 risk groups

被引:40
作者
Wang, FS
Hong, WG
Cao, YZ
Liu, MX
Jin, L
Hu, LP
Wang, Z
Feng, TJ
Hou, J
Zhang, B
Shi, M
Xu, DP
Lei, ZY
Wang, B
Liu, ZD
Ye, JJ
Peng, L
Qiu, Y
Winkler, C
机构
[1] Beijing Hosp Infect Dis, Beijing Inst Infect Dis, Div Biol Engn, Beijing, Peoples R China
[2] Natl Ctr AIDS Prevent & Control, Beijing, Peoples R China
[3] Inst Med Informat, Div Med Stat, Beijing, Peoples R China
[4] Hlth & Antiepidem Ctr Henan Province, Zhengzhou, Peoples R China
[5] Shenzhen Hlth & Antiepidem Stn, Shenzhen, Guangdong Prov, Peoples R China
[6] Hlth & Antiepidem Ctr Xin Jiang Autonomous Reg, Mulomuqi, Peoples R China
[7] Sci & Technol Inst Family Planning, Kunming, Yunnan Province, Peoples R China
[8] NCI, Basic Res Program, SAIC Frederick Inc, Frederick, MD 21701 USA
关键词
coreceptors; SDF-1; CCR2; CCR5; HIV-1; allele frequency;
D O I
10.1097/00126334-200302010-00002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The aim of this study is to determine in indigenous Chinese ethnic groups the frequencies of the chemokine (SDFI 3'A) and chemokine receptors (CCR5 Delta32, CCR5 m303, and CCR2b 641) HIV-1/AIDS restriction alleles. The study includes two cohorts; the first comprised 3165 indigenous healthy subjects representing eight ethnic groups: Han (n = 1406), Uygur (n = 316), Mongolia (n = 134), Hui (n = 386), Tibetan (n = 330), Zhuang (n = 378), Dai (n = 101), and Jingbo (n = 114). The second cohort consisted of 330 HIV-1-infected (86 subjects infected by sexual transmission and 198 subjects infected by HIV-1-contaminated blood or by sharing injection equipment; the remaining 46 subjects said nothing about HIV-1 transmission) and 474 HIV-1-uninfected Han Chinese belonging to one of two HIV-1 high-risk groups: intravenous drug users (n = 215) and individuals with sexually transmitted diseases (n = 259). Genotypes for the four genes were obtained using PCR (CCR5 Delta32) or PCR-restriction fragment length polymorphism. Randomly selected amplified PCR products were further confirmed by direct DNA sequencing. The variant allele frequencies were determined to be 0% to 3.48% for CCR5 Delta32, 0% for CCR5 m303, 16.23% to 28.79% for CCR2b 641, and 17.70% to 27.76% for SDFI 3'A in Chinese healthy individuals from eight ethnic groups. These findings show that allele frequencies differ among the eight Chinese ethnic groups for CCR5 Delta32, CCR2b 641, and SDFI 3'A and that the CCR5 m303 and CCR5 Delta32 mutant alleles were absent or infrequent in Chinese, which may be helpful for studies of specific anti-HIV-1 vaccine trials and coreceptor inhibitor drug targets in Chinese populations. Furthermore, we observed no significant differences in allele or genotypic frequencies between HIV-1-infected and HIV-1-uninfected groups from the Han ethnic group. Our finding is the first reporting that there is likely no effect of the examined polymorphisms in our study on HIV-1 transmission in the Chinese Han population, However, the genetic effects of these and other AIDS-modifying polymorphisms on the pathogenesis and clinical outcome of HIV-1/AIDS diseases is under investigation in Chinese populations.
引用
收藏
页码:124 / 130
页数:7
相关论文
共 36 条
[1]   Influence of CCR5 promoter haplotypes on AIDS progression in African-Americans [J].
An, P ;
Martin, MP ;
Nelson, GW ;
Carrington, M ;
Smith, MW ;
Gong, K ;
Vlahov, D ;
O'Brien, SJ ;
Winkler, CA .
AIDS, 2000, 14 (14) :2117-2122
[2]   The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates [J].
Choe, H ;
Farzan, M ;
Sun, Y ;
Sullivan, N ;
Rollins, B ;
Ponath, PD ;
Wu, LJ ;
Mackay, CR ;
LaRosa, G ;
Newman, W ;
Gerard, N ;
Gerard, C ;
Sodroski, J .
CELL, 1996, 85 (07) :1135-1148
[3]   IDENTIFICATION OF RANTES, MIP-1-ALPHA, AND MIP-1-BETA AS THE MAJOR HIV-SUPPRESSIVE FACTORS PRODUCED BY CD8(+) T-CELLS [J].
COCCHI, F ;
DEVICO, AL ;
GARZINODEMO, A ;
ARYA, SK ;
GALLO, RC ;
LUSSO, P .
SCIENCE, 1995, 270 (5243) :1811-1815
[4]   Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene [J].
Dean, M ;
Carrington, M ;
Winkler, C ;
Huttley, GA ;
Smith, MW ;
Allikmets, R ;
Goedert, JJ ;
Buchbinder, SP ;
Vittinghoff, E ;
Gomperts, E ;
Donfield, S ;
Vlahov, D ;
Kaslow, R ;
Saah, A ;
Rinaldo, C ;
Detels, R ;
OBrien, SJ .
SCIENCE, 1996, 273 (5283) :1856-1862
[5]   Stromal-derived factor-1 chemokine gene variant is associated with the delay of HIV-1 disease progression in two longitudinal cohorts [J].
Dezzutti, CS ;
Guenthner, PC ;
Green, TA ;
Cohen, OJ ;
Spira, TJ ;
Lal, RB .
AIDS, 2000, 14 (07) :894-896
[6]   A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors [J].
Doranz, BJ ;
Rucker, J ;
Yi, YJ ;
Smyth, RJ ;
Samson, M ;
Peiper, SC ;
Parmentier, M ;
Collman, RG ;
Doms, RW .
CELL, 1996, 85 (07) :1149-1158
[7]   HIV-1 entry into CD4(+) cells is mediated by the chemokine receptor CC-CKR-5 [J].
Dragic, T ;
Litwin, V ;
Allaway, GP ;
Martin, SR ;
Huang, YX ;
Nagashima, KA ;
Cayanan, C ;
Maddon, PJ ;
Koup, RA ;
Moore, JP ;
Paxton, WA .
NATURE, 1996, 381 (6584) :667-673
[8]   Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1 [J].
Faure, S ;
Meyer, L ;
Costagliola, D ;
Vaneensberghe, C ;
Genin, E ;
Autran, B ;
Delfraissy, JF ;
McDermott, DH ;
Murphy, PM ;
Debré, P ;
Théodorou, I ;
Combadière, C .
SCIENCE, 2000, 287 (5461) :2274-2277
[9]   HIV-1 Entry Cofactor: Functional cDNA Cloing of a Seven-Transmembrane, G protein-Coupled Receptor [J].
Feng, Yu ;
Broder, Christopher C. ;
Kennedy, Paul E. ;
Berger, Edward A. .
JOURNAL OF IMMUNOLOGY, 2011, 186 (11) :872-877
[10]   Effects of CCR5-Δ32, CCR2-641, and SDF-1 3′A alleles on HIV-1 disease progression:: An international meta-analysis of individual-patient data [J].
Ioannidis, JPA ;
Rosenberg, PS ;
Goedert, JJ ;
Ashton, LJ ;
Benfield, TL ;
Buchbinder, SP ;
Coutinho, RA ;
Eugen-Olsen, J ;
Gallart, T ;
Katzenstein, TL ;
Kostrikis, LG ;
Kuipers, H ;
Louie, LG ;
Mallal, SA ;
Margolick, JB ;
Martinez, OP ;
Meyer, L ;
Michael, NL ;
Operskalski, E ;
Pantaleo, G ;
Rizzardi, GP ;
Schuitemaker, H ;
Sheppard, HW ;
Stewart, GJ ;
Theodorou, ID ;
Ullum, H ;
Vicenzi, E ;
Vlahov, D ;
Wilkinson, D ;
Workman, C ;
Zagury, JF ;
O'Brien, TR .
ANNALS OF INTERNAL MEDICINE, 2001, 135 (09) :782-795